Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-06

FDA Approved: BENZPHETAMINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for benzphetamine hydrochloride developed by Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENZPHETAMINE HYDROCHLORIDE (benzphetamine hydrochloride)

Snippet

SUPPL AP for BENZPHETAMINE HYDROCHLORIDE (BENZPHETAMINE HYDROCHLORIDE)